Schonfeld Strategic Advisors LLC

Position in ZLAB — Zai Lab Ltd

CIK 1665241 NEW YORK, NY

Position in ZLAB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$294,424

-$411,264 QoQ

Shares Held

15,496

-61.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 92 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ZLAB ranks #97 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$294,424	15,496	-61.3%	Shares	Sole	2026-08-14
2025-12-31	$705,688	40,005	-29.2%	Shares	Sole	2026-02-17
2025-06-30	$1,974,860	56,473	-55.3%	Shares	Sole	2025-08-14
2024-12-31	$3,305,230	126,202	-43.6%	Shares	Sole	2025-02-14
2024-03-31	$3,584,410	223,746	+1213.4%	Shares	Sole	2024-05-15
2023-03-31	$566,584	17,035	-20.8%	Shares	Sole	2023-05-15
2022-03-31	$946,141	21,513	-45.6%	Shares	Sole	2022-05-16
2021-09-30	$4,165,434	39,524	+2534.9%	Shares	Sole	2021-11-16
2021-06-30	$265,485	1,500	-94.0%	Shares	Sole	2021-11-16
2021-03-31	$3,335,750	25,000	-21.4%	Shares	Sole	2021-05-17
2020-09-30	$2,644,390	31,795	-90.3%	Shares	Sole	2020-11-19
2020-06-30	$26,947,510	328,108	+110.5%	Shares	Sole	2020-08-14
2020-03-31	$8,023,724	155,861	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.